SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON)
MSON 26.540.0%Nov 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wesley0428 who wrote (607)1/17/1998 6:39:00 PM
From: David S.   of 947
 
2 truths - I was the person who mentioned the Paresi patents were evaluated by MSON before MNTR bought, which indicates the MSON thought they were as valuable as a rat's ass but it is also true that the amount of prior art is significant, so both factors would suggest that the MNTR attempt should not work. If the legal efforts of MNTR are judged to be a nuisance, can MSON countersue for triple damanges? Perhaps an attorney who is lurking can comment. I am not an attorney, but I make great burgers at Johnny Rockets at 3rd and Main.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext